These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 16172211
1. Crypt-restricted loss and decreased protein expression of cytochrome C oxidase subunit I as potential hypothesis-driven biomarkers of colon cancer risk. Payne CM, Holubec H, Bernstein C, Bernstein H, Dvorak K, Green SB, Wilson M, Dall'Agnol M, Dvorakova B, Warneke J, Garewal H. Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2066-75. PubMed ID: 16172211 [Abstract] [Full Text] [Related]
2. Expression of mitochondrial cytochrome c oxidase in human colonic cell differentiation, transformation, and risk for colonic cancer. Heerdt BG, Halsey HK, Lipkin M, Augenlicht LH. Cancer Res; 1990 Mar 01; 50(5):1596-600. PubMed ID: 2154329 [Abstract] [Full Text] [Related]
3. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression. Greco C, Alvino S, Buglioni S, Assisi D, Lapenta R, Grassi A, Stigliano V, Mottolese M, Casale V. Anticancer Res; 2001 Mar 01; 21(5):3185-92. PubMed ID: 11848471 [Abstract] [Full Text] [Related]
4. A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. Bernstein C, Bernstein H, Garewal H, Dinning P, Jabi R, Sampliner RE, McCuskey MK, Panda M, Roe DJ, L'Heureux L, Payne C. Cancer Res; 1999 May 15; 59(10):2353-7. PubMed ID: 10344743 [Abstract] [Full Text] [Related]
5. Transforming growth factor alpha distribution in rectal crypts as a biomarker of decreased colon cancer risk in patients consuming cellulose. Hardman WE, Cameron IL, Beer WH, Speeg KV, Kadakia SC, Lang KA. Cancer Epidemiol Biomarkers Prev; 1997 Aug 15; 6(8):633-7. PubMed ID: 9264277 [Abstract] [Full Text] [Related]
6. Biomarkers correlate with colon cancer and risks: a preliminary study. Lu S, Chiu YS, Smith AP, Moore D, Lee NM. Dis Colon Rectum; 2009 Apr 15; 52(4):715-24. PubMed ID: 19404080 [Abstract] [Full Text] [Related]
7. Simultaneous exposure to dietary acrylamide and corn oil developed carcinogenesis through cell proliferation and inhibition of apoptosis by regulating p53-mediated mitochondria-dependent signaling pathway. Zhang X. Toxicol Ind Health; 2009 Mar 15; 25(2):101-9. PubMed ID: 19458132 [Abstract] [Full Text] [Related]
8. Colonic epithelial cell expression of ICAM-1 relates to loss of surface continuity: a comparative study of inflammatory bowel disease and colonic neoplasms. Vainer B, Horn T, Nielsen OH. Scand J Gastroenterol; 2006 Mar 15; 41(3):318-25. PubMed ID: 16497620 [Abstract] [Full Text] [Related]
9. The role of Reg IV gene and its encoding product in gastric carcinogenesis. Zheng HC, Xu XY, Yu M, Takahashi H, Masuda S, Takano Y. Hum Pathol; 2010 Jan 15; 41(1):59-69. PubMed ID: 19740514 [Abstract] [Full Text] [Related]
10. Autocrine gastrins in colon cancer cells Up-regulate cytochrome c oxidase Vb and down-regulate efflux of cytochrome c and activation of caspase-3. Wu H, Rao GN, Dai B, Singh P. J Biol Chem; 2000 Oct 20; 275(42):32491-8. PubMed ID: 10915781 [Abstract] [Full Text] [Related]
11. Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Gianani R, Jarboe E, Orlicky D, Frost M, Bobak J, Lehner R, Shroyer KR. Hum Pathol; 2001 Jan 20; 32(1):119-25. PubMed ID: 11172305 [Abstract] [Full Text] [Related]
12. Differential Expression of Cytochrome C Oxidase Subunit I Along the Colorectal Adenoma: Carcinoma Progression. Hewedi IH, Farid RM, Sidhom KF, Salman MI, Mostafa RG. Appl Immunohistochem Mol Morphol; 2018 Oct 20; 26(9):689-696. PubMed ID: 28362707 [Abstract] [Full Text] [Related]
13. Reliability of rectal epithelial kinetic patterns as an intermediate biomarker of colon cancer. Anti M, Marra G, Percesepe A, Armelao F, Gasbarrini G. J Cell Biochem Suppl; 1994 Oct 20; 19():68-75. PubMed ID: 7823608 [Abstract] [Full Text] [Related]
14. Differential expression of IGF-binding protein-3 in normal and malignant colon and its influence on apoptosis. Jenkins PJ, Khalaf S, Ogunkolade W, McCarthy K, David T, Hands RE, Davies D, Bustin SA. Endocr Relat Cancer; 2005 Dec 20; 12(4):891-901. PubMed ID: 16322329 [Abstract] [Full Text] [Related]
15. A study of some mitochondrial and peroxisomal enzymes in human colonic adenocarcinoma. Sun AS, Sepkowitz K, Geller SA. Lab Invest; 1981 Jan 20; 44(1):13-7. PubMed ID: 6256583 [Abstract] [Full Text] [Related]
16. Clinical implications of fibroblast activation protein in patients with colon cancer. Henry LR, Lee HO, Lee JS, Klein-Szanto A, Watts P, Ross EA, Chen WT, Cheng JD. Clin Cancer Res; 2007 Mar 15; 13(6):1736-41. PubMed ID: 17363526 [Abstract] [Full Text] [Related]
17. Altered expression and localization of creatine kinase B, heterogeneous nuclear ribonucleoprotein F, and high mobility group box 1 protein in the nuclear matrix associated with colon cancer. Balasubramani M, Day BW, Schoen RE, Getzenberg RH. Cancer Res; 2006 Jan 15; 66(2):763-9. PubMed ID: 16424007 [Abstract] [Full Text] [Related]
18. Gal-GalNAc: a biomarker of colon carcinogenesis. Yang GY, Shamsuddin AM. Histol Histopathol; 1996 Jul 15; 11(3):801-6. PubMed ID: 8839767 [Abstract] [Full Text] [Related]